Two new independent directors, Sarah Hofstetter, President of Profitero, and Erica Mann, former President and Head of Bayer’s Consumer Health Division, were appointed to the company’s Board of Directors. Also, Jeffrey Smith, Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP will join the Board.
Larry Merlo, Chair of Kenvue’s Board, said,
“We are pleased to welcome Sarah, Erica, and Jeff as new directors on Kenvue’s Board. Sarah’s brand building and digital marketing expertise, Erica’s global consumer health industry experience, and Jeff’s investor perspective and extensive service on corporate boards will further strengthen the Board with complementary, value-additive skillsets.”
Hofstetter will serve as a member of the Audit Committee, Mann will serve as a member of the Nominating, Governance & Sustainability Committee, and Smith will serve as a member of the Compensation & Human Capital Committee.
Sarah Hofstetter
Hofstetter currently serves as President of Profitero, Ltd., a global e-commerce SaaS analytics company. She has significant brand building, e-commerce, and digital marketing expertise from her career leading organizations that use advertising to drive growth.
Hofstetter previously served as President of ComScore and held several senior executive roles at 360i, a U.S. advertising arm of Dentsu, a Japanese advertising and public relations company, including serving as Chairwoman, Chief Executive Officer, and Senior Vice President, Emerging Media & Brand Strategy.
Earlier in her career, Hofstetter was the President and Founder of Kayak Communications and served in a series of senior leadership positions over 10 years at Net2Phone. She currently serves on the board of directors of The Campbell’s Company.
Erica Mann
Mann is a globally experienced leader, having lived and worked across four continents, with deep expertise in consumer health, emerging markets, strategic trend analysis, culture, and risk management. She previously served as Global President of Bayer’s Consumer Health Division for seven years.
Before joining Bayer, Mann was the President and General Manager of Pfizer Nutrition, having joined Pfizer upon its acquisition of Wyeth, where she had served as the Senior Vice President of Global Nutrition.
Mann has held roles of increasing responsibility at other Fortune 500 companies, including Eli Lilly and Johnson & Johnson, and leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland, and the U.S.
She currently serves on the boards of directors of ALS Limited, DSM-Firmenich AG, and Kellanova. Mann previously served on the boards of directors of Perrigo Company plc and Blackmores Limited.
Jeffrey C. Smith
Smith is a Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, an investment adviser with a focused and fundamental approach to investing primarily in publicly traded U.S. companies.
Before founding Starboard Value LP in April 2011, Smith served as the Chief Investment Officer for the funds that comprised the Value and Opportunity investment platform at Ramius LLC, where he was a Partner Managing Director. Before joining Ramius, he served as Vice President of Strategic Development and a member of the Board of Directors of The Fresh Juice Company.
Smith began his career in the Mergers and Acquisitions department at Société Générale. Previously, Mr. Smith served as Chair of the Boards of Directors of Papa John’s International, Advance Auto Parts, Darden Restaurants, and Phoenix Technologies.
Read Next
Kenvue Announces Full Year and Q4 2024 Financial Results
Kenvue Names New President
